MEI Pharma, Inc.·4

Sep 9, 4:52 PM ET

White Christine Anna 4

4 · MEI Pharma, Inc. · Filed Sep 9, 2019

Insider Transaction Report

Form 4
Period: 2019-09-06
Transactions
  • Purchase

    Common Stock

    2019-09-06$1.74/sh+15,000$26,07515,000 total
Footnotes (2)
  • [F1]The shares purchased by the reporting person are held through an Individual Retirement Account.
  • [F2]The weighted average purchase price for the transaction reported was $1.7383, and the range of prices was between $1.725 and $1.74. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares purchased at each separate price will be provided.

Documents

1 file
  • 4
    doc4.xmlPrimary

    FORM 4 SUBMISSION